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Abstract
c-Myc is a transcriptional factor that functions as a central regulator of cell growth, proliferation, and apoptosis.
Overexpression of c-Myc also enhances DNA double-strand breaks (DSBs), genetic instability, and tumorigenesis.
However, the mechanism(s) involved remains elusive. Here, we discovered that γ-ray ionizing radiation–induced
DSBs promote c-Myc to form foci and to co-localize with γ-H2AX. Conditional expression of c-Myc in HO15.19 c-Myc
null cells using the Tet-Off/Tet-On inducible system results in down-regulation of Ku DNA binding and suppressed
activities of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and DNA end-joining, leading to inhibition
of DSB repair and enhanced chromosomal and chromatid breaks. Expression of c-Myc reduces both signal and
coding joins with decreased fidelity during V(D)J recombination. Mechanistically, c-Myc directly interacts with Ku70
protein through its Myc box II (MBII) domain. Removal of the MBII domain from c-Myc abrogates its inhibitory effects
on Ku DNA binding, DNA-PKcs, and DNA end-joining activities, which results in loss of c-Myc’s ability to block DSB
repair and V(D)J recombination. Interestingly, c-Myc directly disrupts the Ku/DNA-PKcs complex in vitro and in vivo.
Thus, c-Myc suppression of DSB repair and V(D)J recombination may occur through inhibition of the nonhomologous
end-joining pathway, which provides insight into the mechanism of c-Myc in the development of tumors through
promotion of genomic instability.
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Introduction
DNA double-strand breaks (DSBs) result not only from by-products
of endogenous metabolism, such as oxidative metabolism, DNA rep-
lication, or V(D)J recombination for immune system development,
but also from exogenous sources, including ionizing radiation (IR),
chemical agents, UV light, and cancer chemotherapeutics. DSBs are
extremely dangerous, toxic lesions with severe consequences for
cellular survival and genomic integrity [1]. The failure to repair or
inappropriate repair of DSBs can cause cell death or large-scale chro-
mosomal changes including deletions, translocations, and chromosome
fusions that may lead to neoplastic transformation and ultimately
cancer development [2]. In mammalian cells, DSBs are repaired mainly
by two kinds of mechanisms: nonhomologous end-joining (NHEJ)
and homologous recombination (HR), and deficiencies in either path-
way can lead to genomic instability and promote tumorigenesis [3,4].
DSBs trigger a series of signaling cascades that lead to the recruit-
ment of DNA repair proteins to the sites of genomic damage and
formation of repair complex foci at the site of the break. One of
the earliest events in the DNA damage response is the phosphoryla-
tion of histone H2A variant at the serine 139 position leading to the
generation of γ-H2AX, a key regulator of IR-induced nuclear foci
formation [5–7]. Ataxia telangiectasia mutated and DNA-dependent
protein kinase catalytic subunit (DNA-PKcs) play essential but par-
tially redundant roles in phosphorylating H2AX in response to DSBs
[8,9]. The phosphorylated H2AX functions as a scaffold for the
accumulation and retention of the central components of the signal-
ing cascade initiated by DNA damage [1]. DNA ligase IV, along with
its binding partners, XRCC4 and XLF (also called Cernunnos) [10],
seals the break in the final step of the DSB repair. The nuclease Artemis
helps repair a subset of IR-induced DSBs by NHEJ and is important
for opening hairpins.
It is known that DSBs induced by exogenous agents are potentially
harmful lesions for cells. However, physiological DSBs are also gen-
erated by recombination activating genes (RAG1/2) during V(D)J
recombination [11], which are essential for immune system develop-
ment. This reaction produces recombination signal (RS) ends con-
taining blunt 5′ phosphorylated DSBs and coding ends in the form
of covalently sealed hairpins [12]. Importantly, joining of RS and cod-
ing ends during V(D)J recombination also requires the NHEJ DNA
repair pathway [13,14]. Because V(D)J recombination is a physio-
logical process in B and T cell development [11], suppression of the
NHEJ DNA repair pathway not only negatively affects general DSB
repair but may also inhibit V(D)J recombination and subsequently
impair immune system development.
c-Myc is a transcription factor and functions as a central signaling
switch for a variety of cellular processes including cellular growth and
proliferation, differentiation, angiogenesis, cell adhesion, and apop-
tosis [15]. c-Myc has been implicated as an important factor in the
onset or progression of many types of cancer and is frequently over-
expressed in up to 70% of all human malignancies [16,17]. c-Myc dys-
regulation directly promotes genomic instability and tumorigenesis
[15,18–21]. Additionally, c-Myc can induce DNA breakage, alter
DNA break repair [22,23], and cause chromosomal breaks and trans-
locations in normal human cells [24]. Such Myc-mediated activities are
undoubtedly central to its role in tumorigenesis. However, the mecha-
nisms by which c-Myc dysregulation leads to DNA breakage and
genomic instability are poorly understood. It was previously reported
that expression of c-Myc upregulates reactive oxygen species (ROS)
leading to increased DNA damage [25]. In contrast, a more recent
study demonstrated that c-Myc activation in vivo or in vitro under
a physiologically relevant oxygen environment does not induce ROS
production but can still result in the formation of DNA breaks [26].
These results support the concept that c-Myc overexpression can
induce widespread DNA damage independent of ROS. Although
a link between c-Myc dysregulation and DSBs has been known
for many years, the direct mechanism(s) by which c-Myc enhances
DSBs remains elusive. Because the NHEJ factors (i.e., Ku70 and
Ku86) have recently been identified as c-Myc–associated proteins
by a combined TAP/MudPIT approach [27], this provides possi-
bility that c-Myc could directly regulate the repair of DSBs. Here,
we provide direct evidence demonstrating that c-Myc inhibits DSB
repair and V(D)J recombination through direct suppression of the
NHEJ pathway. These findings have important implications for under-
standing the relationship between pleiotropic oncogenes, DNA repair
pathways, and tumorigenesis.
Materials and Methods
Materials
Ku70, Ku86, DNA-PKcs, and c-Myc antibodies were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Purified recom-
binant c-Myc protein was purchased from Active Motif (Carlsbad,
CA). Purified recombinant Ku70 protein was obtained from GenWay
Biotech, Inc (San Diego, CA). The γ-H2AX antibody was purchased
from Upstate Biotech (Charlotteville, VA). Ku70/Ku86 DNA Repair
Kit was obtained from Active Motif. The SignaTECT DNA-PK Assay
Kit was purchased from Promega (Madison, WI). c-Myc small inter-
fering RNA (siRNA) and control siRNA were purchased from Ambion
(Austin, TX). DNase I was obtained from Sigma-Aldrich (St Louis,
MO). The pJH290, pJH200, RAG1, and RAG2 constructs as well
as Escherichia coli MC1061 were obtained from Dr Frederick W. Alt
(Harvard Medical School). HO15.19 c-Myc null cells were provided
by Dr John M. Sedivy (Brown University). Other reagents used were
obtained from commercial sources unless otherwise stated.
Generation of Various c-Myc Deletion Mutants
A series of c-Myc deletion mutants, including ΔMBI, ΔMBII, and
ΔHLH, were created using Transformer Site-Directed Mutagenesis
Kit (Clontech, Mountain View, CA) according to the manufacturer’s
instructions. The 5′-phosphorylated mutagenic primers for various
precise deletion mutants were synthesized as follows: ΔMBI [amino
acids (aa) 45–63], 5′-GCA GAG CGA GCT GCA GCC CCC GGC
GAGCCGCCGCTCCGGGCT-3′;ΔMBII (aa 129–143), 5′-GAC
CCG GAC GAC GAG ACC TTC ATC AAA AAC ATC CTC GTC
TCA GAG AAG CTG GCC TCC TAC CAG GCT G-3′; ΔHLH
(aa 368–410), 5′-GTC TTG GAG CGC CAG AGG AGG CAA
AAG CTC ATT TCT G-3′. The wild-type (WT) c-Myc/pUC19 con-
struct was used as the target plasmid, which contains a unique NdeI
restriction site for selection against the unmutated plasmid. The NdeI
selection primer is 5′-GAGTGCACCATGGGCGGTGTGAAA-3′.
Each single mutant was confirmed by sequencing of the cDNA.WT and
each of the c-Myc deletion mutants were then cloned into the response
plasmid pTRE2hyg (Clontech) or the pcDNA3.1 (Invitrogen, Grand
Island, NY) mammalian expression vector, respectively.
Cell Lines, Plasmids, and Conditional Expression of c-Myc
H460, H157, and H1299 cells were maintained in RPMI 1640
medium with 10% FBS. HO15.19 c-Myc null cells were grown in
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Dulbecco’s modified Eagle’s medium supplemented with 10% calf
serum as described [28]. For conditional expression of c-Myc, the
Tet-On inducible gene expression system (Clontech) was established
in HO15.19 cells according to the manufacturer’s instructions. First,
pTet-On plasmids containing E. coli lacZ under control of the Tet
response element (TRE) were transfected into HO15.19 cells. Stable
clones were selected by G418 (0.8 mg/ml). Second, WT c-Myc
cDNA was cloned into the pTRE2hyg vector between the BamHI
and EcoRV restriction sites. Finally, the stable Tet-On cells were
transfected with the response plasmid pTRE2hyg containing c-Myc
and selected using hygromycin. c-Myc expression under control of the
TRE in double-stable cells was turned on by the addition of doxy-
cycline (DOX, 1 μg/ml).
Immunofluorescence
The cells were washed with 1× phosphate-buffered saline (PBS),
fixed with cold methanol and acetone (1:1) for 5 minutes, and then
blocked with 10% normal mouse or rabbit serum for 60 minutes
at room temperature. Cells were incubated with a rabbit (i.e., c-Myc)
or mouse (i.e., γ-H2AX) primary antibody for 90 minutes. After
washing, samples were incubated with Alexa 488 (green)–conjugated
anti-rabbit or Alexa 594 (red)–conjugated anti-mouse secondary
antibodies or 4′,6-diamidino-2-phenylindole (DAPI) for 60 minutes.
Cells were washed with 1× PBS and observed under a fluorescent
microscope (Zeiss). Pictures were taken and colored with the same
exposure setting for each experiment. Individual green- and red-stained
images derived from the same field were merged using Openlab 3.1.5
software from Improvision, Inc (Lexington, MA).
Measurement of Ku70/86 Activity
Ku70/Ku86 DNA binding activity was analyzed using a Ku70/86
DNA Repair Kit (Active Motif). Briefly, cells were washed and resus-
pended in hypotonic buffer. The nuclear extract was isolated for Ku
activity analysis. Five micrograms of nuclear protein was loaded into
the oligonucleotide-coated 96-well plate and incubated for 60 min-
utes at room temperature. Ku70 or Ku86 antibody was added and
incubated for another 60 minutes. After washing, HRP-conjugated
secondary antibody was added and incubated for 60 minutes. After
washing, developing solution and stop solution were added. Optical
density was read on a spectrophotometer at 450 nm. Each experi-
ment was repeated three times and data represent the mean ± SD
of three separate determinations.
Pulsed-Field Gel Electrophoresis
Pulsed-field gel electrophoresis (PFGE) was performed as described
previously [29]. Briefly, cells were harvested, resuspended in ice-cold
buffer L [0.1 M Na2-EDTA, 0.01 M Tris, 0.02 M NaCl (pH 8.0)] at
a concentration of 5 × 106 cells/ml, and mixed with an equal volume
of 1% low melting point agarose (Beckman) at 42°C. The mixture
was pipetted into a small length of Tygon tubing, clamped tight
at both ends, and chilled to 0°C. The solidified agarose “snake”
was extruded from the tubing, added to 10× volume of buffer L con-
taining 1 mg/ml proteinase K and 1% sarkosyl, and incubated for
16 hours at 50°C. Following lysis, the agarose snake was washed four
times with TE buffer and then cut into 0.5-cm plugs. The plugs were
inserted into the wells of a pre-cooled 1% low melting point agarose
gel (4°C). PFGE (200-s pulse time, 150 V, 15 hours at 14°C) was
performed using Clamped Homogenous Electric Fields Mapper
(Bio-Rad, Hercules, CA). After electrophoresis, the gel was stained
with ethidium bromide for photography.
Telomere–Fluorescence In Situ Hybridization Analysis
Telomere–Fluorescence In Situ Hybridization (T-FISH) was per-
formed using Telomere peptide nucleic acid (PNA) FISH Kit/Cy3
(DakoCytomation, Copenhagen, Denmark) as described [30]. Cells
were incubated with colcemid (KaryoMAX; Gibco, Grand Island, NY)
at 100 ng/ml for 1.5 hours and then harvested by trypsinization. Cells
were swollen in pre-warmed 30 mM sodium citrate for 30 minutes at
37°C, fixed in methanol/acetic acid (3:1), and air dried on slides over-
night. After pepsin digestion, slides were denatured at 80°C for 5minutes,
hybridized with Cy3-labeled PNA telomeric probe (Cy3-[TTAGGG]3)
in 70% formamide at room temperature for 3 to 4 hours, washed, dehy-
drated, and mounted in Vectashield with DAPI (Vector Laboratories,
Burlingame, CA). Metaphase images were captured using a fluorescent
microscope (Zeiss) and ×63 objective lens. At least 30 metaphases of
each cell line were scored for chromosomal aberrations.
Transient V(D)J Recombination Assay
Recombination substrates pJH200 and pJH290 were used in the
transient V(D)J recombination assay to test for RS and coding joins
as described [31]. Briefly, pJH200 or pJH290 was co-transfected
into cells with the full-length RAG1 and RAG2 expression constructs
under the control of the Rous sarcoma virus long terminal repeat
promoter using Lipofectamine 2000. Extrachromosomal DNA was
recovered after 48 hours by alkaline lysis as previously described
[32] and electroporated into E. coli MC1061. The V(D)J recombi-
nation activity was measured by comparing the ratio of ampicillin-
resistant (Ampr) and chloramphenicol-resistant (Camr) colonies versus
Ampr colonies in cells. Because a precise signal join generates an
ApaLI site, ApaLI digestion of polymerase chain reaction products
from the recombinant substrate pJH 200 was used to measure the
fidelity of the RS joins as described [31]. The coding join sequence
was determined by comparison of the nucleotide sequence isolated
from individual recombined pJH290 clones.
Results
IR Induces Formation of c-Myc Foci and DSBs
It has been reported that c-Myc overexpression is associated with
abnormalities in chromosomal number, chromosomal breaks, and
translocations [33]. It is possible that c-Myc–induced genetic insta-
bility may result from increased DNA damage and/or reduced DNA
repair. Formation of γ-H2AX foci is considered to be a sensitive and
selective signal for the presence of DSBs and an early event following
DSB induction [34,35]. Here, we found that, in addition to γ-H2AX
foci, IR can also induce formation of c-Myc foci in a dose-dependent
manner in H1299 cells (Figure 1A). Both c-Myc and γ-H2AX foci
are gradually reduced over a 12-hour time period following IR expo-
sure (Figure 1B). These findings suggest that IR-induced DNA
damage signals may facilitate the recruitment of c-Myc molecules
to the vicinity of broken ends of double-strand DNA. Importantly,
majority of IR-induced c-Myc foci are co-localized with γ-H2AX
because the strong yellow foci could be observed in the merged
images (Figures 1 and W1), indicating that c-Myc may play a role
in regulating the repair of IR-induced DSBs. Similar results were
observed in H460 and H157 cells after IR exposure (Figure W1A),
1192 c-Myc Suppresses DSB Repair Li et al. Neoplasia Vol. 14, No. 12, 2012
suggesting that the IR-induced formation of c-Myc foci is not confined
to a specific cell type. Importantly, after silence of c-Myc using c-Myc
siRNA, only γ-H2AX (red) without green signal of c-Myc could be
observed following DNA damage (Figure W1B), indicating that the
antibody used is truly staining c-Myc.
Conditional Expression of c-Myc Results in Suppression of DSB
Repair and Increased Genetic Instability in Association with
Decreased Ku, DNA-PKcs, and DNA End-joining Activities
DSBs can be repaired by two pathways: HR andNHEJ [36,37]. How-
ever, NHEJ is the major pathway in mammalian cells for repairing
Figure 1. IR induces formation of c-Myc foci and DSBs. (A) H1299 cells were treated with increasing doses of IR (0–10 Gy). After radiation,
c-Myc and γ-H2AX were analyzed immediately by immunofluorescent staining. (B) H1299 cells were treated with IR (5 Gy). Cells were
harvested at various time points as indicated. c-Myc and γ-H2AX were analyzed by immunofluorescent staining.
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DSBs [36,38]. Ku70, Ku86, and DNA-PKcs are the major compo-
nents of the NHEJ machinery required for DSB repair [36–38]. We
observed that c-Myc molecules may be recruited to the broken ends
of double-strand DNA following DNA damage (Figure 1). To further
address the role of c-Myc in DSB repair, c-Myc was conditionally ex-
pressed in the HO15.19 c-Myc null cells using the Tet-Off/Tet-On
inducible gene expression system. In this system, c-Myc expression
can only be turned on by the addition of DOX (Figure 2A). DOX itself
Figure 2. Conditional expression of c-Myc downregulates Ku DNA binding activity and suppresses DSB repair leading to increased
genetic instability. (A) HO15.19 cells bearing inducible Tet-Off/Tet-On c-Myc gene were established as described in Materials and Meth-
ods section. c-Myc was turned on in three independent stable clones by the addition of DOX (1 μg/ml) for 24 hours. Expression levels of
c-Myc, Ku70, and Ku86 were analyzed by Western blot. (B) DNA binding activity of Ku70 or Ku86 in c-Myc–Off or c-Myc–On cells was
measured using a Ku70/86 DNA Repair Kit. Error bars represent ± SD. (C and D) The c-Myc–Off and c-Myc–On HO15.19 cells were
exposed to 5 Gy of IR. Cells were harvested at various time points. DSBs were determined by PFGE or analysis of γ-H2AX by immuno-
staining. The number of γ-H2AX foci per cell was determined on a cell-to-cell basis by the quantitative analysis of at least 30 randomly
chosen cells as described [58]. The percentage of γ-H2AX foci–positive cells was determined by analyzing 100 randomly chosen cells as
described [34]. Error bars represent ± SD. (E and F) c-Myc was turned on by addition of DOX for 4 weeks. Then, percentage of abnormal
metaphases in the c-Myc–Off or c-Myc–On cells was quantified by T-FISH analysis. At least 30 metaphases per culture were analyzed.
Error bars represent ± SD. Frequency of cytogenetic abnormality per metaphase in c-Myc–Off or c-Myc–On cells. Each experiment was
repeated three times and error bars represent ± SD.
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has no effect on expression of c-Myc and Ku in HO15.19 parental
cells without the Tet-Off/Tet-On inducible gene expression system
(Figure W2). This helps to rule out potential effect of DOX treatment.
Intriguingly, conditional expression of c-Myc significantly inhibits the
DNA binding activity of both Ku70 and Ku86 by more than 50%
compared to the c-Myc–Off control (Figure 2, A and B). Similar results
were obtained from three independent clones expressing similar levels
of exogenous c-Myc, indicating that these findings are reliable. Electro-
phoretic mobility shift assays (EMSAs) were employed to assess the
extent of Ku DNA binding and provided further confirmation that
Ku DNA binding is dramatically decreased in the c-Myc–On cells
compared to c-Myc–Off cells (Figure W3A). Collectively, these results
suggest that conditional overexpression of c-Myc may interfere with
the binding of Ku to dsDNA broken ends.
To test the effect of c-Myc on DNA-PKcs activity in HO15.19 cells,
a substrate phosphorylation assay was employed and revealed that
conditional expression of c-Myc also results in down-regulation of
DNA-PKcs activity (Figure W3B). In addition, c-Myc also inhibits
DNA end-joining activity (Figure W3C). Because NHEJ is thought to
be the major DSB repair pathway in mammalian cells [39–41], c-Myc–
mediated inhibition of Ku, DNA-PKcs, and DNA end-joining activ-
ities may lead to suppression of DSB repair. To test this possibility,
PFGE of genomic DNA under neutral conditions was employed to
directly measure the level of DSBs [29]. Following IR exposure, a sig-
nificant amount of genomic DNA from all cells migrated into the gel,
indicating DNA fragmentation (i.e., DSBs). In c-Myc–Off cells, DSB
repair was nearly completed in 24 hours following IR exposure as
evidenced by little or no shortened DNA fragments migrating into
the gel (Figure 2C ). In contrast, DNA fragmentation (presence of
DSBs) could still be observed 48 hours following IR exposure in the
c-Myc–On cells (Figure 2C). DSBs were also evaluated by analysis of
γ-H2AX foci [7]. IR is a potent inducer for formation of γ-H2AX foci
in both c-Myc–Off and c-Myc–On cells (Figure W3D). The intensity
of foci staining, the number of γ-H2AX foci per cell, as well as the
overall percentage of foci-positive cells are significantly reduced by 12
to 24 hours post-IR exposure in c-Myc–Off cells. An increased number
of γ-H2AX foci with greater staining intensities per cell and a higher
percentage of foci-positive cells were observed in c-Myc–On cells com-
pared to c-Myc–Off cells 12 to 24 hours post-IR exposure (Figures 2D
and W3D). Western blot analysis of γ-H2AX levels confirmed that
expression of c-Myc significantly prolongs the presence of γ-H2AX
in cells following IR exposure (Figure W3E). Collectively, these find-
ings directly indicate that c-Myc inhibits the repair of IR-induced
DSBs through suppression of the NHEJ pathway.
c-Myc can cause chromosomal rearrangements through telomere
and chromosome remodeling in the interphase nucleus [24]. To di-
rectly test the effect of c-Myc on chromosomal aberrations, a FISH
assay that combines DAPI staining with a telomere-specific PNA probe
(T-FISH) was employed to evaluate metaphase chromosomes for
instability [30]. Increased levels of cytogenetic abnormalities, including
chromosomal and chromatid breaks, were observed in c-Myc–On cells
compared to c-Myc–Off control cells (Figures 2, E and F , and
W4). These findings demonstrate that c-Myc suppression of DSB
repair may lead to increased genetic instability.
c-Myc Directly Interacts with Ku
To test the effect of IR-induced DSBs on c-Myc and Ku interaction,
a co-immunoprecipitation (co-IP) experiment using a c-Myc antibody
was performed following exposure of H1299 cells with increasing doses
of IR. IR-induced DSBs promote c-Myc to directly associate with
Ku70 (Figure 3A). To rule out the possible involvement of DNA in
this interaction, cell lysates were first treated with 150 KU DNase I
for 5 minutes. A co-IP was performed with c-Myc antibody as de-
scribed [42]. Results reveal that c-Myc still interacts with Ku70 after
digestion of DNA (Figure 3B). Additionally, a direct interaction be-
tween c-Myc and Ku was also confirmed by co-IP using purified re-
combinant c-Myc and Ku70 proteins in vitro (Figure 3C).
c-Myc Interacts with Ku70 through Its MBII Domain
that Is Required for c-Myc Suppression of
NHEJ-mediated DSB Repair
The c-Myc protein comprised several functional domains. The
N-terminal structure contains the highly conserved Myc box I
(MBI, aa 45–63) and Myc box II (MBII, aa 129–143) domains
that determine the transcription-regulatory activity of c-Myc [43].
The C-terminal structure is composed of helix-loop-helix (HLH,
aa 368–410) and leucine zipper (aa 410–439) regions, which are
essential for Myc-Max heterodimerization [43,44]. To identify the
Ku binding site in c-Myc protein, a series of c-Myc deletion mu-
tants, including ΔMBI (aa 45–63), ΔMBII (aa 129–143), and ΔHLH
(aa 368–410), were generated (Materials and Methods section).
WT c-Myc or each of the c-Myc deletion mutants were expressed
Figure 3. c-Myc interacts with Ku70. (A) H1299 cells were treated
with increasing doses of IR (0–15 Gy). co-IP was carried out using
c-Myc antibody. Ku70 and c-Myc were analyzed by Western blot.
(B) H1299 cells were treated with IR (5 Gy). co-IP was performed
with anti-Myc antibody or normal IgG in the presence or absence
of 150 KU of DNase I. Ku70 and c-Myc were analyzed by Western
blot. (C) Purified recombinant c-Myc was incubated with purified
Ku70 in lysis buffer at 4°C for 2 hours. A co-IP was performed using
a c-Myc antibody or normal IgG control. Ku70 and c-Myc were ana-
lyzed by Western blot.
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in HO15.19 c-Myc null cells (Figure 4A). Interestingly, expression of
WT c-Myc or any of the c-Myc deletion mutants does not affect the
expression level of Ku70 (Figure 4A, left panel ). This result is consis-
tent with the recent report that c-Myc knockdown inhibits Rad51 but
does not affect Ku70 expression [45]. A co-IP experiment revealed that
Ku70 is able to associate with WT c-Myc, ΔMBI, and ΔHLH c-Myc
mutants but not with the ΔMBII c-Myc mutants (Figure 4A, right panel ),
indicating that the MBII domain is the Ku binding site on c-Myc.
To test the functional effects of c-Myc/Ku binding on NHEJ and
DSB repair, Ku DNA binding, DNA-PKcs, and DNA end-joining
Figure 4. Ku70 directly interacts with c-Myc through its MBII domain, which is essential for c-Myc suppression of DSB repair. (A) WT or
each of the c-Myc deletion mutants was transfected into HO15.19 cells. Expression levels of c-Myc were analyzed by Western Blot.
Additionally, a co-IP was performed using Ku70 antibody. The Ku-associated c-Myc was analyzed by Western blot. White arrow(s) points
c-Myc or c-Myc deletion mutant protein band(s). (B) DNA binding activity of Ku70 or Ku86 in HO15.19 cells expressing WT or each of the
c-Myc deletion mutants was measured using a Ku70/86 DNA Repair Kit. Error bars represent ± SD. (C–E) HO15.19 cells expressing WT
or each of the c-Myc deletion mutants were exposed to 5 Gy of IR. After 24 hours, DSBs were measured by PFGE or analysis of γ-H2AX
by immunostaining with quantitative evaluation as described in the legend of Figure 2.
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activities, as well as DSB repair, were compared in HO15.19 cells
expressing similar levels of WT c-Myc or each of the c-Myc deletion
mutants. Expression of WT c-Myc, ΔMBI, and ΔHLH c-Myc
mutants but not the ΔMBII c-Myc mutant significantly suppresses
Ku DNA binding, DNA-PKcs, and DNA end-joining activities
(Figures 4B and W5, A and B). Functionally, deletion of the MBII
domain from c-Myc results in failure of c-Myc to inhibit the repair of
IR-induced DSBs, as determined by PFGE or analysis of γ-H2AX by
immunostaining (Figure 4, C–E ). In contrast, removal of the MBI
or HLH domain does not affect the ability of c-Myc to inhibit DSB
repair. This supports the notion that the binding of c-Myc to Ku
through the MBII domain may be required for the inhibitory effects
of c-Myc on Ku DNA binding, DNA-PKcs, and DNA end-joining
activities resulting in inhibition of DSB repair.
A T-FISH assay revealed that more than 80% of cells were
engaged in abnormal metaphase with increased chromosomal and
chromatid breaks observed in HO15.19 cells expressing WT c-Myc,
ΔMBI, or ΔHLH c-Myc mutants (Figure W5, C andD). Intriguingly,
deletion of MBII from c-Myc results in loss of c-Myc’s effect on genetic
instability, as demonstrated by the significant reduction in chromo-
somal and chromatid breaks in HO15.19 cells expressing ΔMBII
c-Myc mutant compared to WT c-Myc (Figure W5, C and D).
These findings indicate that the MBII domain may also be required
for c-Myc–mediated genomic instability.
c-Myc Directly Disrupts the Ku/DNA-PKcs Complex
DNA-PK is composed of the Ku70/86 heterodimer and the
DNA-PK catalytic subunit (DNA-PKcs) that exists as a large functional
Figure 5. c-Myc directly disrupts the Ku/DNA-PKcs complex. (A and B) The Ku70/DNA-PKcs or Ku86/DNA-PKcs complex was co-
immunoprecipitated from HO15.19 cells and incubated with purified c-Myc (10–20 ng/ml) in EBC lysis buffer at 4°C for 2 hours. After
centrifugation, the resulting supernatant and immunocomplex beads were subjected to sodium dodecyl sulfate–polyacrylamide gel
electrophoresis. Ku, c-Myc, and DNA-PKcs that bound to Ku or unbound DNA-PKcs present in the supernatant were then analyzed by
Western blot. (C) HO15.19 cells expressing WT or each of the c-Myc deletion mutants were disrupted in EBC lysis buffer. co-IP was per-
formed using an agarose-conjugated Ku70 or Ku86 antibody, respectively. The Ku-associated DNA-PKcs was then analyzed by Western
blot. Normal rabbit IgG was used as a control.
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Figure 6. Depletion of endogenous c-Myc by RNAi enhances Ku DNA binding, DNA-PKcs, and DNA end-joining activities in association
with accelerated DSB repair. (A) H460 cells expressing high levels of endogenous c-Myc were transfected with c-Myc siRNA or control
siRNA. Expression of c-Myc was analyzed by Western blot. (B–D) Ku DNA binding, DNA-PKcs, and DNA end-joining activities were
measured in H460 cells expressing c-Myc siRNA and control siRNA. (E–H) H460 cells expressing c-Myc siRNA or control siRNA were
exposed to 5 Gy of IR. After 24 hours, DSBs were measured by PFGE or analysis of γ-H2AX by immunostaining with quantitative eval-
uation as described in the legend of Figure 2.
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complex [46]. To directly test whether c-Myc affects Ku70/DNA-PKcs
association, the Ku70/DNA-PKcs complex was co-immunoprecipitated
from H1299 cells using a Ku70 or Ku86 antibody. The immune com-
plex was incubated with purified recombinant c-Myc and proteins
released from the complex were identified in the supernatant follow-
ing centrifugation. Because the addition of purified c-Myc results
in decreased levels of bound DNA-PKcs and increased levels of non-
bound DNA-PKcs (Figure 5, A and B), this suggests that c-Myc can
directly disrupt the Ku70/DNA-PKcs complex under cell-free condi-
tions in vitro. To further test whether c-Myc affects Ku/DNA-PKcs
complex in intact cells, WT c-Myc or each of the c-Myc deletion
mutants was overexpressed in HO15.19 c-Myc null cells. Co-IP exper-
iments revealed that overexpression of WT c-Myc, ΔMBI, or ΔHLH
c-Myc mutants but not the ΔMBII c-Myc mutant potently suppresses
the Ku/DNA-PKcs association (Figure 5C). This result indicates that
deletion of the MBII domain from c-Myc results in loss of c-Myc’s
ability to disrupt the Ku/DNA-PKcs binding. Thus, the inhibitory
effect of c-Myc on Ku/DNA-PKcs binding requires the MBII domain
(i.e., Ku binding site).
Knockdown of c-Myc by RNA Interference Results in
Up-regulation of Ku DNA Binding, DNA-PKcs, and DNA
End-joining Activities and Accelerates DSB Repair
To test the effect of c-Myc at physiological level on NHEJ and
DSB repair, endogenous c-Myc was depleted from H460 cells by
RNA interference (RNAi). Transfection of c-Myc siRNA significantly
reduces the expression level of endogenous c-Myc by more than 80%
but does not affects Ku expression in H460 cells (Figure 6A). This
effect of siRNA on c-Myc expression is highly specific because the
control siRNA has no effect. Functionally, knockdown of endogenous
c-Myc by RNAi upregulates Ku DNA binding, DNA-PKcs, and
DNA end-joining activities in association with accelerated repair
of IR-induced DSBs, as determined by both PFGE and analysis of
γ-H2AX by immunostaining (Figure 6). These findings strongly sug-
gest that physiologically expressed c-Myc in cells is able to suppress
DSB repair by a mechanism involving the NHEJ pathway.
Conditional Expression of c-Myc Inhibits Formation of RS
and Coding Joins in V(D)J Recombination
Ku and DNA-PKcs are required for joining of both RS and coding
ends during V(D)J recombination [14,31]. Because our results showed
that c-Myc suppresses both Ku and DNA-PKcs activities (Figures 2
and W3), it is also possible that c-Myc may negatively affect V(D)J re-
combination. To test this possibility, we assessed the ability of RAG-
transfected HO15.19 cells expressing exogenous WT c-Myc or each
of the c-Myc deletion mutants (i.e., ΔMBI, ΔMBII or ΔHLH) to
undergo V(D)J recombination within the context of transiently trans-
fected substrates designed to test the formation of either RS joins
(pJH200) or coding joins (pJH290), as described previously [31]. At
least four independent transfection experiments were carried out with
each cell line. Expression of WT c-Myc or ΔMBI or ΔHLH c-Myc
mutants results in significant impairment in the ability to form both
RS and coding joins compared to vector-only control (Table 1). The
Ku binding capacity of c-Myc may be essential for this effect because
overexpression of the Ku binding–deficient ΔMBII c-Myc mutant has
no significant effect on either RS or coding joins formation (Table 1).
It is known that a precise RS join generates an ApaLI site and that the
loss of nucleotides from the RS ends will prevent the formation of the
ApaLI site. Digestion of polymerase chain reaction products generated
from the recombination substrate pJH 200 with the ApaLI restriction
Table 1. Effect of c-Myc on RS and Coding Joining.
Cell Line pJH200 (RS Joining) pJH290 (Coding Joining)
(Ampr + Camr )/Ampr % Relative Level Fidelity % (Ampr + Camr )/Ampr % Relative Level
Experiment 1
HO15.19
Vector 95/12111 0.78 1 100 (14/14) 103/6250 1.64 1
WT 24/40101 0.06 0.08 28 (4/14) 10/15430 0.06 0.04
ΔMBI 30/38400 0.08 0.1 42 (6/14) 12/22800 0.05 0.03
ΔMBII 105/14101 0.74 0.95 100 (14/14) 172/10867 1.58 0.95
ΔHLH 24/12577 0.19 0.24 35 (5/14) 17/16110 0.1 0.06
Experiment 2
HO15.19
Vector 119/14500 0.82 1 100 (14/14) 161/17980 0.89 1
WT 33/40110 0.08 0.09 42 (6/14) 52/44560 0.12 0.12
ΔMBI 51/45890 0.11 0.13 28 (4/14) 111/33420 0.33 0.37
ΔMBII 77/10900 0.7 0.85 100 (14/14) 255/29840 0.85 0.95
ΔHLH 22/25990 0.08 0.09 35 (7/14) 67/33220 0.2 0.22
Experiment 3
HO15.19
Vector 129/19500 0.66 1 100 (14/14) 322/36745 0.88 1
WT 32/32300 0.09 0.13 57 (8/14) 59/32412 0.18 0.2
ΔMBI 21/20310 0.1 0.15 64 (9/14) 119/38567 0.31 0.35
ΔMBII 48/8430 0.57 0.86 100 (14/14) 234/31010 0.75 0.85
ΔHLH 45/35400 0.13 0.2 57 (8/14) 131/45991 0.28 0.32
Experiment 4
HO15.19
Vector 145/23500 0.62 1 100 (14/14) 245/31300 0.8 1
WT 25/30800 0.08 0.12 57 (8/14) 78/43200 0.18 0.23
ΔMBI 21/20100 0.1 0.16 71 (10/14) 87/28400 0.31 0.38
ΔMBII 50/10300 0.49 0.79 100 (14/14) 153/23200 0.66 0.82
ΔHLH 43/32300 0.13 0.21 71 (10/14) 178/63800 0.27 0.34
RS and coding joins were measured in HO15.19 cells expressing WT or each of the c-Myc deletion mutants. Four independent transfection experiments were carried out with each cell line.
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enzyme was carried out for the analysis of fidelity of the RS joins [31].
Intriguingly, only 28% to 71% of the RS joins recovered fromHO15.19
cells expressing WT c-Myc, ΔMBI, or ΔHLH c-Myc mutants could be
cut by ApaLI (Table 1), indicating that expression of c-Myc also reduces
the fidelity of RS joins. This is dependent on the Ku binding capacity of
c-Myc, because expression of the Ku binding–deficient ΔMBII c-Myc
mutant does not affect the fidelity of RS joins (Table 1). Thus, in ad-
dition to the general DSB repair process, c-Myc may also negatively
regulate the repair of DSBs generated by RAG1/2 during the V(D)J
recombination reaction.
To test whether c-Myc induces mutation or deletion during the pro-
cess forming coding joins, the nucleotide sequences of the products of
coding joins were compared in HO15.19 cells expressing WT c-Myc
and each of the c-Myc deletion mutants [14,47]. Comparison of coding
junctions revealed that extensive nucleotide deletions (i.e., >10 bp) were
observed in the clones from HO 15.19 cells expressing WT c-Myc and
ΔMBI or ΔHLH c-Myc mutants compared to cells expressing the
Ku binding–deficient ΔMBII c-Myc mutant or vector-only control
(Table 2). These findings indicate that, in addition to RS joins, c-Myc
also reduces the fidelity of coding joins formation, which requires the
MBII domain (Tables 1 and 2).
Discussion
c-Myc is a potent oncogenic molecule and its overexpression contrib-
utes to the development of human cancers [48]. The genomic dam-
age induced by c-Myc can be broadly grouped into two classes of
abnormalities. First, overexpression of c-Myc induces loss of chromo-
somal integrity associated with chromosomal aberrations such as
gene amplifications, double minutes, and fusions. c-Myc may also
contribute to tumorigenesis by destabilizing the cellular genome. Sec-
ond, c-Myc overexpression can cause inappropriate DNA replication,
resulting in endoreduplication. c-Myc uncouples DNA replication
from mitosis with implications for genomic instability [49].The for-
mer type of genomic abnormality can be caused by defects in the re-
pair of DSBs because overexpression of c-Myc not only causes DSBs
but also disrupts their repair [23,48,50]. However, the direct molec-
ular mechanism(s) by which c-Myc enhances occurrence of DSBs
and genetic instability are not fully understood. In the present study,
we discovered at first time that conditional expression of c-Myc in
HO15.19 cells downregulates Ku DNA binding, DNA-PKcs, and
DNA end-joining activities resulting in suppression of DSB repair and
increased genomic instability (Figures 2, W3, and W4), indicating that
the inhibitory effect of c-Myc on DSB repair is likely to occur through a
mechanism involving the NHEJ pathway. IR-induced DSB signals not
only promote the formation of c-Myc foci that co-localize with γ-H2AX
but also facilitate c-Myc interaction with Ku70 (Figures 1 and 3). This
suggests that c-Myc may locate at DSB sites and bind to Ku proteins
following IR exposure, which could prevent NHEJ factors from binding
broken DNA ends, leading to suppression of DNA end-joining. Ad-
ditionally, the inhibitory effect of DSB repair by c-Myc can help
explain why c-Myc could enhance apoptosis seen in the context of
DNA-damaging agents [51,52]. Previous reports indicate that c-Myc
can also inhibit HR [23,45], suggesting that c-Myc may also regulate
DSB repair through the HR pathway. HR appears to be the predom-
inant mechanism of DSB repair in yeast, which is operative only in the
S/G2 phases of the cell cycle when a sister chromatid is available. By
contrast, NHEJ, which simply pieces together the broken DNA ends,
can function in all phases of the cell cycle. Therefore, NHEJ is the
major pathway in mammalian cells for repairing DSBs [36,38]. Here,
we discovered that, in addition to HR, c-Myc may play a more impor-
tant role in regulating DSB repair by suppressing NHEJ in mammalian
cells. This uncovers a novel mechanism by which c-Myc negatively
regulates DSB repair.
In addition to the well-known functions as transcription factor,
c-Myc also has nontranscriptional functions [53,54]. Our results reveal
that expression of WT c-Myc or the c-Myc deletion mutant(s) did not
alter the Ku expression level (Figures 2A and 4A). On the basis of these
findings, the inhibitory effect of c-Myc on DSB repair may not be a
consequence of c-Myc regulation of Ku DNA repair gene transcription.
This may occur through a nontranscriptional function of c-Myc (e.g.,
a direct interaction with Ku protein). It has been recently reported that
c-Myc can interact with Ku70, but the Ku binding domain in c-Myc
is not clear [27]. It is known that the highly conserved MBII domain
of c-Myc is critical for the transactivation of target genes [43,55]. Here,
we found that c-Myc is able to directly interact with Ku70 in vitro and
in cells (Figure 3). Furthermore, structure-function studies identified
that the MBII domain of c-Myc is the Ku binding site (Figure 4A).
Importantly, removal of the Ku binding site (i.e.,ΔMBII domain) from
c-Myc results in loss of its ability to suppress Ku DNA binding, DNA-
PKcs, DNA end-joining, and DSB repair and failure to enhance
chromosomal and chromatid breaks (Figures 4 and W5). These find-
ings not only indicate a role of c-Myc in suppression of NHEJ but also
demonstrate that a direct interaction between c-Myc and Ku through
MBII domain is required for its inhibitory effects on NHEJ and DSB
repair, as well as for its role in chromosomal instability.
Recruitment of DNA-PKcs by the Ku complex to the broken
DNA ends and formation of the functional Ku/DNA-PKcs com-
plexes are essential for DSB repair [36]. It has been proposed that
c-Myc may disrupt formation of DNA repair complexes and/or dis-
rupt chromatin structure, preventing efficient DNA repair [26].
However, there is to date no published report that substantiates this
hypothesis. Here, we discovered that c-Myc not only interacts with
Table 2. Effect of c-Myc on Coding Joining Sequence.
Left Coding Flank Right Coding Flank No. Clones
TTGGGCTGCAGGTCGAC GGATCCCCGGGGATCAGC
Vector TTGGGCTGCAGGT ATCCCCGGGGATCAGC 1
TTGGGCTGCAGGTCG GGATCCCCGGGGATCAGC 3
TTGGGCTGCAGG GGATCCCCGGGGATCAGC 2
TTGGGCTGCAGGTCGA ATCCCCGGGGATCAGC 3
TTGGGCTGCAGGTCGA CCCCGGGGATCAGC 1
WT TTGGGCTGCAGGTCG GGATCCCCGGGGATCAGC 1
TTGG TCAGC 2
TTGGGCTG GGATCAGC 2
TT GC 3
TTGGGCTG GGGATCAGC 2
ΔMBI TTGGGCTGCAGG 2
TTGGGCTGCA AGC 2
TTGGG GGGGATCAGC 2
TTGGGC CGGGGATCAGC 1
TTGGGCTGCA AGC 1
TTGGG 2
ΔMBII TTGGGCTGCAGGT CCCCGGGGATCAGC 2
TTGGGCTGCAGGTC ATCCCCGGGGATCAGC 2
TTGGGCTGCAGGTCGAC GGATCCCCGGGGATCAGC 2
TTGGGCTGCAG GATCCCCGGGGATCAGC 2
ΔHLH TTGGGCTGCAG CCGGGGATCAGC 1
GATCCCCGGGGATCAGC 3
TTGGGCTG 3
TTGGGCTGCAGGT ATCCCCGGGGATCAGC 3
Aberrant coding join sequences from HO15.19 cells expressing WT or each of the c-Myc deletion
mutants. Individual clones from the double selection plates were isolated and sequenced.
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Ku through its MBII domain (Figures 3 and 4) but also directly dis-
sociates DNA-PKcs from Ku/DNA-PKcs complex (Figure 5, A and
B). Overexpression of WT, ΔMBI, or ΔHLH but not ΔMBII c-Myc
mutant in HO15.19 cells significantly suppresses Ku/DNA-PKcs
association (Figure 5C ), indicating that the MBII domain of c-Myc
is required for the c-Myc/Ku binding as well as for disruption of Ku/
DNA-PKcs complex. These findings support the notion that c-Myc/Ku
binding may functionally interfere with Ku-mediated recruitment of
DNA-PKcs to the broken DNA ends, which will eventually lead to
suppression of DSB repair.
V(D)J recombination has been considered a physiological DSB re-
pair process in which the NHEJ proteins are recruited to specifically
repair broken ends such as the signal and hairpin coding ends gen-
erated by RAG1/2 [31,56]. Here, we discovered that overexpression
of c-Myc results in decreased formation of RS and coding joins with
reduced fidelity (i.e., nucleotide mutations or deletions; Tables 1 and
2), as assayed by co-transfection of RAG1 and RAG2 expression vec-
tors along with plasmid V(D)J recombination substrates (pJH200 or
pJH290), as described [31]. Because the Ku binding–deficient c-Myc
mutant (i.e., ΔMBII) has no such effect, this indicates that the inhib-
itory effect of c-Myc on V(D)J recombination may require c-Myc/Ku
binding to suppress the NHEJ pathway. Because both general DSB
repair and V(D)J recombination require Ku and DNA-PKcs, this ex-
plains why c-Myc plays a role in general DSB repair similar to that
observed in V(D)J recombination. Translocations occur spontane-
ously but more often in cells deficient in DSB repair. Misrepair of
DSBs introduced during V(D)J recombination can promote onco-
genic translocations [11]. Therefore, c-Myc–induced oncogenic
translocation may result, at least in part, from its inhibitory effect
on DSB repair and V(D)J recombination. Because V(D)J recombi-
nation is a required process for immune system development [11],
c-Myc–mediated inhibition of V(D)J recombination may also impair
the immune system. Thus, the role of c-Myc in DSB repair and
genetic instability, together with its negative effects on V(D)J recom-
bination and immune system development, may cooperatively pro-
mote tumor formation. Although this is a reconstituted in vitro
system, the data from this system discovered at first time that c-Myc
has direct role in regulating V(D)J recombination. On the basis of these
findings, future studies will be required to further characterize the role
of c-Myc on V(D)J recombination in B or T cells or transgenic mice
that selectively target B or T cells.
In summary, our results reveal that c-Myc inhibition of DSB repair
and V(D)J recombination most likely occurs through direct suppres-
sion of the NHEJ pathway. The DNADSB signal promotes c-Myc foci
formation and interaction with Ku through its MBII domain, which
is required for c-Myc to inhibit Ku DNA binding, formation of Ku/
DNA-PKcs complexes, DNA-PK activity, DNA end-joining, DSB re-
pair, and V(D)J recombination. It is known that V(D)J recombination
is crucial to the development of the adaptive immune system, providing
B and T cells the capacity to generate a virtually unlimited repertoire of
antigen receptors [57]. On the basis of our findings, we propose that
the inhibitory effects of c-Myc on DSB repair and V(D)J recombina-
tion may lead to accumulation of DSBs in living cells, increased genetic
instability, and impairment of the immune system, which eventually
contribute to the development of various types of cancer.
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Supplementary Methods
Preparation of Cell Lysates
Cells were washed with 1× PBS and resuspended in ice-cold
0.5% NP-40 EBC lysis buffer [0.5% NP-40, 50 mM Tris (pH 7.6),
120 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 50 mM NaF, and
1 mM β-mercaptoethanol] with a cocktail of protease inhibitors
(Calbiochem, Billerica, MA). Cells were lysed by sonication and centri-
fuged at 14,000g for 10 minutes at 4°C. The resulting supernatant was
collected as the total cell lysate and used for Western blot or co-IP as
described [1].
DNA-PK Activity Assay
The SignaTECT DNA-PK Assay Kit was used to measure DNA-
PK activity (Promega). First, the following reaction mixtures in the
presence or absence of activator was prepared (i.e., 2.5 μl of DNA-
PK activation buffer or control buffer, 5.0 μl of DNA-PK in 5×
reaction buffer, 2.5 μl of DNA-PK biotinylated peptide substrate,
0.2 μl of BSA (10 mg/ml), and 5 μl of [γ-32P]ATP). The mixture
was pre-incubated at 30°C for 4 minutes. The whole-cell extract sam-
ple was diluted in the enzyme buffer and the reaction was initiated by
adding the appropriate amount of enzyme sample and incubated at
30°C for 5 minutes. The reaction was stopped by addition of termi-
nation buffer. Sample was spotted onto the SAM2R Biotin Capture
membrane. The membrane was then washed and dried under a heat
lamp for 10 minutes. DNA-PK enzyme activity was determined by
scintillation counting. Each experiment was repeated three times and
data represent the mean ± SD of three separate determinations.
In Vivo DNA End-joining Assay
The pGL3 plasmid (Promega), in which expression of the luciferase
gene is controlled by the CMV promoter, was used to evaluate correct
NHEJ activity that precisely rejoins broken DNA ends in vivo as
described [2]. The pGL3 plasmid was completely linearized by the
restriction endonuclease NarI, which cleaves within the luciferase
coding region as confirmed by agarose gel electrophoresis. The line-
arized DNA was purified and then dissolved in sterilized water. A 20:1
mixture of the linearized pGL3 plasmid and pTK Renilla control
luciferase reporter vector (an internal control) was transfected into cells.
After 48 hours, luciferase activity was measured using a dual luciferase
assay system following the manufacturer’s instruction (Promega). Be-
cause the pGL3 reporter plasmid was digested to completion withNarI
within the luciferase coding region, only precise DNA end-joining can
restore the luciferase activity. Each experiment was repeated three times
and data represent the mean ± SD of three separate determinations.
Electrophoretic Mobility Shift Assay
Ku DNA binding was analyzed by EMSA as described [3]. Briefly,
two complementary 79-nucleotide oligonucleotides were denatured
and then annealed to generate a 71-bp fragment with BamHI over-
hangs at each end. These two oligonucleotides are given as follows:
Oligonucleotide 1, GAT CCT CTG AGG ACA CAG CCT TGT
ATT ACT GTG CAA GAC ACA CAA TGA GCA AAA GTT ACT
GTG AGC TCA AAC TAA AAC C and Oligonucleotide 2, GAT
CGG TTT TAG TTT GAG CTC ACA GTA ACT TTT GCT
CAT TGT GTG TCT TGC ACA GTA ATA CAA GGC TGT
GTA CTC AGA G. The fragments were labeled with T4 poly-
nucleotide kinase in the presence of [γ-32P]ATP. Ku protein binding
activity was measured by a nondenatural gel EMSA. Each reaction
mixture of 20 μl contained 0.5 ng of radiolabeled probe, 1.5 μl of
nuclear extract, and 1 μg of supercoiled competitor DNA (pJG4-5)
in binding buffer [15 mM Hepes (pH 7.9), 50 mM NaCl, 5 mM
MgCl, 1 mM DTT, 0.5 mM EDTA, 1 mM Tris-HCl (pH 7.9), and
5% glycerol]. For all binding assays, the protein was added last and the
reaction mixture was incubated at room temperature for 20 minutes.
The reaction mixture was resolved by nondenaturing electropho-
resis through a 6% polyacrylamide gel in 0.53 Tris-borate-EDTA
buffer. The gel was dried on Whatman 3M paper and exposed to
Kodak film.
RNA Interference
H460 cells expressing endogenous c-Myc were transfected with
c-Myc siRNA using Lipofectamine 2000 (Invitrogen). A control
siRNA (nonhomologous to any known gene sequence) was used as
a negative control. The levels of c-Myc expression were analyzed by
Western blot analysis. Specific silencing of the targeted c-Myc gene
was confirmed by at least three independent experiments.
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Figure W2. DOX has no effect on expression of c-Myc, Ku70, and
Ku86 in HO15.19 parental c-Myc null cells. HO15.19 parental cells
were treated with DOX for 24 hours. c-Myc, Ku70, and Ku86 were
analyzed by Western blot.
Figure W1. IR induces formation of c-Myc foci and DSBs in various types of human lung cancer cells. (A) H460 or H157 cells were
treated with IR (5 Gy). c-Myc and γ-H2AX were analyzed immediately by immunofluorescent staining using primary anti–c-Myc (rabbit)
and anti–γ-H2AX (mouse) antibodies as well as Alex 488 (green)–conjugated anti-rabbit or Alexa 594 (red)–conjugated anti-mouse sec-
ondary antibodies. (B) H1299 cells were transfected with c-Myc siRNA or control siRNA. Cells expressing c-Myc siRNA or control siRNA
were treated with IR (5 Gy). c-Myc and γ-H2AX were analyzed by immunofluorescent staining as described in A.
Figure W3. Conditional expression of c-Myc results in decreased DNA-PK, DNA end-joining, and DNA Ku binding activities in association
with suppression of DSB repair. (A) The c-Myc–Off and c-Myc–On HO15.19 cells were exposed to 5 Gy of IR. Ku DNA binding was
analyzed by EMSA. (B) DNA-PK activity was measured using the SignaTECT DNA-PK Assay Kit in c-Myc–Off or c-Myc–On cells. Error
bars represent ± SD. (C) DNA end-joining activity was measured in c-Myc–Off or c-Myc–On HO15.19 cells. Error bars represent ± SD.
(D and E) The c-Myc–Off and c-Myc–On HO15.19 cells were exposed to 5 Gy of IR. Cells were incubated in normal culture medium for
various times. DSBs were determined by analysis of γ-H2AX by immunostaining and Western blot using γ-H2AX antibody.
Figure W4. Conditional expression of c-Myc results in increased genetic instability. (A) Representative cytogenetic abnormalities were
analyzed by T-FISH in c-Myc–Off and c-Myc–On HO15.19 cells (addition of DOX for 4 weeks). DAPI-stained chromosomes are shown in
blue. Red dots come from telomere signals.
Figure W5. The ΔMBII domain of c-Myc is essential for c-Myc suppression of DNA-PK and DNA end-joining activities, as well as for
enhanced genetic instability. (A) DNA-PK activity was measured using the SignaTECT DNA-PK Assay Kit in HO15.19 cells expressing WT
or each of c-Myc deletionmutants. Error bars represent ± SD. (B) DNA end-joining activity wasmeasured in HO15.19 cells expressingWT or
each of c-Myc deletion mutants. Error bars represent ± SD. (C and D) Percentage of abnormal metaphases and frequency of cytogenetic
abnormality per metaphase from HO15.19 cells expressing WT or each of c-Myc deletion mutants were quantified by T-FISH analysis. At
least 30 metaphases per culture were analyzed. Each experiment was repeated three times and error bars represent ± SD.
